Blog

Excision BioTherapeutics Licenses New CRISPR Systems from UC Berkeley – Genetic Engineering & Biotechnology News (press release)

Excision BioTherapeutics Licenses New CRISPR Systems from UC Berkeley
Genetic Engineering & Biotechnology News (press release)
Excision BioTherapeutics has become the first company to exclusively license new CRISPR systems discovered last year by Jennifer Doudna, Ph.D., a pioneer of the gene-editing technology, and Jillian Banfield, Ph.D., for use in developing treatments

2017-11-13 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.